Search results
Regal Investment Advisors LLC Has $1.19 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 11 hours agoRegal Investment Advisors LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.6% in the 4th quarter, HoldingsChannel reports. The firm owned 10,800 shares ...
Abbott secures FDA clearance for two over-the-counter glucose monitors
Reuters via Yahoo News· 1 day ago(Reuters) -Abbott Laboratories said on Monday the U.S. health regulator had cleared the company's...
FDA approves two new Abbott over-the-counter continuous glucose monitors
CNBC· 1 day agoAbbott Laboratories announced on Monday it received approval from the U.S. Food and Drug...
2 Magnificent Dividend Growth Stocks to Buy Now
Motley Fool via Yahoo Finance· 5 hours agoDividend growth stocks have long been revered by investors as powerful vehicles for compounding wealth over the long term. By consistently increasing...
Abbott Laboratories's Options: A Look at What the Big Money is Thinking - Abbott Laboratories...
Benzinga· 1 day agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Abbott Laboratories ABT , and it's something market players shouldn't ignore. Our tracking of public options ...
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 23 hours agoAbbott Laboratories gained U.S. clearance Monday for a pair of new continuous glucose monitors. But...
Abbott Laboratories (NYSE:ABT) Stake Raised by Westwood Holdings Group Inc.
ETF DAILY NEWS· 2 days agoWestwood Holdings Group Inc. grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The ...
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers
Forbes· 2 days agoAbbott Laboratories Monday said the U.S. Food and Drug Administration has cleared for sale two new...
Abbott Laboratories loses bid to halt Glucerna class action
Reuters· 5 days agoLitigation claiming that Abbott Laboratories is marketing Glucerna shakes and nutritional powders with harmful ingredients can move forward, a California federal judge said Wednesday. , opens ...
